acebutolol has been researched along with Cardiovascular Pregnancy Complications in 10 studies
Acebutolol: A cardioselective beta-1 adrenergic antagonist with little effect on the bronchial receptors. The drug has stabilizing and quinidine-like effects on cardiac rhythm, as well as weak inherent sympathomimetic action.
acebutolol : An ether that is the 2-acetyl-4-(butanoylamino)phenyl ether of the primary hydroxy group of 3-(propan-2-ylamino)propane-1,2-diol.
| Excerpt | Relevance | Reference |
|---|---|---|
| "The main purpose of our study was to analyse efficacy and safety of acebutolol (Sectral) in the treatment of hypertension in pregnancy." | 9.10 | [Acebutolol in the treatment of arterial hypertension in pregnancy--comparison with commonly used hypertensive agents]. ( Kriska, M; Letkovicová, M; Mlyncek, M; Sirotiaková, J, 2002) |
| "Twenty pregnant women with mild to moderate hypertension were treated with either methyldopa or acebutolol, a beta-adrenergic blocking agent with cardioselectivity and intrinsic sympathomimetic activity, in a prospective open study." | 7.66 | A comparison of acebutolol with methyldopa in hypertensive pregnancy. ( Morrissey, JR; Williams, ER, 1983) |
| "02; 2--A more frequent adjustment of daily dosage with MD (n = 15) than with ACE (n = 10) or LAB (n = 7); 3--The absence of any significant difference for uricemia level, platelet counts, foetal cardiac rythm, and occurrence of pre-eclampsia (MD = 4; ACE = 3; LAB = 4; 4--An equivalent birth-weight (MD = 3110 +/- 628 g; ACE = 3115 +/- 645." | 6.66 | [Randomized, comparative study on the treatment of moderate arterial hypertension during pregnancy: methyldopa, acebutolol, labetalol]. ( Blazquez, G; Gérard, J; Lardoux, H; Leperlier, E, 1988) |
| "The main purpose of our study was to analyse efficacy and safety of acebutolol (Sectral) in the treatment of hypertension in pregnancy." | 5.10 | [Acebutolol in the treatment of arterial hypertension in pregnancy--comparison with commonly used hypertensive agents]. ( Kriska, M; Letkovicová, M; Mlyncek, M; Sirotiaková, J, 2002) |
| "A 29-year-old primigravida, diagnosed with ARVD 1 year prior to pregnancy, underwent a full-term, uncomplicated pregnancy and delivery while maintained on acebutolol and an implanted cardioverter defibrillator." | 3.73 | Arrhythmogenic right ventricular dysplasia in pregnancy: a case report. ( Bathgate, SL; Lee, LC; Macri, CJ, 2006) |
| "A prospective study of the hemodynamic and renal changes was undertaken in 11 neonates whose mothers were treated with acebutolol for hypertension during pregnancy, compared with a control group of 11 infants born to normotensive mothers." | 3.68 | [Hemodynamic and renal adaptation of newborn infants of hypertensive mothers treated with acebutolol]. ( Boutroy, MJ; Monin, P; Vert, P; Yassen, H, 1992) |
| "Twenty pregnant women with mild to moderate hypertension were treated with either methyldopa or acebutolol, a beta-adrenergic blocking agent with cardioselectivity and intrinsic sympathomimetic activity, in a prospective open study." | 3.66 | A comparison of acebutolol with methyldopa in hypertensive pregnancy. ( Morrissey, JR; Williams, ER, 1983) |
| "Systolic blood pressure, heart rate, and blood glucose concentration were measured in the first three days of life in 10 infants born to mothers who had received acebutolol, a cardioselective beta-adrenergic-blocking agent, for hypertension in pregnancy and compared with values in 10 infants whose mothers had received methyldopa." | 3.66 | Neonatal effects of maternal administration of acebutolol. ( Amiel-Tison, C; Dumez, Y; Hornych, H; Tchobroutsky, C, 1981) |
| "02; 2--A more frequent adjustment of daily dosage with MD (n = 15) than with ACE (n = 10) or LAB (n = 7); 3--The absence of any significant difference for uricemia level, platelet counts, foetal cardiac rythm, and occurrence of pre-eclampsia (MD = 4; ACE = 3; LAB = 4; 4--An equivalent birth-weight (MD = 3110 +/- 628 g; ACE = 3115 +/- 645." | 2.66 | [Randomized, comparative study on the treatment of moderate arterial hypertension during pregnancy: methyldopa, acebutolol, labetalol]. ( Blazquez, G; Gérard, J; Lardoux, H; Leperlier, E, 1988) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 7 (70.00) | 18.7374 |
| 1990's | 1 (10.00) | 18.2507 |
| 2000's | 2 (20.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Lee, LC | 1 |
| Bathgate, SL | 1 |
| Macri, CJ | 1 |
| Moses, JW | 1 |
| Borer, JS | 1 |
| Dubois, D | 2 |
| Petitcolas, J | 2 |
| Temperville, B | 1 |
| Klepper, A | 1 |
| Catherine, P | 1 |
| Williams, ER | 1 |
| Morrissey, JR | 1 |
| Dumez, Y | 1 |
| Tchobroutsky, C | 1 |
| Hornych, H | 1 |
| Amiel-Tison, C | 1 |
| Boutroy, MJ | 2 |
| Vert, P | 2 |
| Bianchetti, G | 1 |
| Dubrucq, C | 1 |
| Morselli, PL | 1 |
| Sirotiaková, J | 1 |
| Mlyncek, M | 1 |
| Kriska, M | 1 |
| Letkovicová, M | 1 |
| Yassen, H | 1 |
| Monin, P | 1 |
| Lardoux, H | 1 |
| Blazquez, G | 1 |
| Leperlier, E | 1 |
| Gérard, J | 1 |
1 review available for acebutolol and Cardiovascular Pregnancy Complications
| Article | Year |
|---|---|
Beta-adrenergic antagonists in the treatment of patients with heart disease.
Topics: Acebutolol; Adrenergic beta-Agonists; Alprenolol; Animals; Arrhythmias, Cardiac; Bronchial Spasm; Ca | 1981 |
2 trials available for acebutolol and Cardiovascular Pregnancy Complications
| Article | Year |
|---|---|
[Acebutolol in the treatment of arterial hypertension in pregnancy--comparison with commonly used hypertensive agents].
Topics: Acebutolol; Adolescent; Adult; Antihypertensive Agents; Female; Humans; Hypertension; Pregnancy; Pre | 2002 |
[Randomized, comparative study on the treatment of moderate arterial hypertension during pregnancy: methyldopa, acebutolol, labetalol].
Topics: Acebutolol; Adult; Female; Heart Rate, Fetal; Humans; Hypertension; Hypoglycemia; Infant, Newborn; L | 1988 |
7 other studies available for acebutolol and Cardiovascular Pregnancy Complications
| Article | Year |
|---|---|
Arrhythmogenic right ventricular dysplasia in pregnancy: a case report.
Topics: Acebutolol; Adult; Anti-Arrhythmia Agents; Arrhythmogenic Right Ventricular Dysplasia; Combined Moda | 2006 |
Treatment of hypertension in pregnancy with beta-adrenoceptor antagonists.
Topics: Abnormalities, Drug-Induced; Acebutolol; Adrenergic beta-Antagonists; Adult; Apgar Score; Atenolol; | 1982 |
A comparison of acebutolol with methyldopa in hypertensive pregnancy.
Topics: Acebutolol; Adult; Apgar Score; Birth Weight; Blood Pressure; Female; Humans; Hypertension; Infant, | 1983 |
Neonatal effects of maternal administration of acebutolol.
Topics: Acebutolol; Blood Glucose; Blood Pressure; Female; Heart Rate; Humans; Hypertension; Infant, Newborn | 1981 |
Infants born to hypertensive mothers treated by acebutolol. Pharmacological studies in the perinatal period.
Topics: Acebutolol; Adult; Blood Pressure; Female; Hemodynamics; Humans; Hypertension; Infant, Newborn; Kine | 1982 |
[beta-blockers and high risk pregnancies. Viewpoint of the nephrologist and the obstetrician].
Topics: Acebutolol; Adrenergic beta-Antagonists; Female; Humans; Hypertension; Pindolol; Pregnancy; Pregnanc | 1978 |
[Hemodynamic and renal adaptation of newborn infants of hypertensive mothers treated with acebutolol].
Topics: Acebutolol; Diuresis; Female; Hemodynamics; Humans; Hypertension; Infant, Newborn; Kidney; Pregnancy | 1992 |